Unusual presentation of metastatic hepatocellular carcinoma in an HIV/HCV coinfected patient: Case report and review of the literature

Tumori

Volumn 94, Issue 4, 2008, Pages 589-591

  Berretta, Massimiliano ^a   Zanet, Ernesto ^a   Di Benedetto, Fabrizio ^b   Simonelli, Cecilia ^a   Bearz, Alessandra ^a   Morra, Aldo ^a   Bonanno, Santo ^c   Berretta, Salvatore ^c   Tirelli, Umberto ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Hepatocellular carcinoma; HIV; Metastases

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ANAMNESIS; ARTICLE; BONE METASTASIS; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LIVER CELL CARCINOMA; MASSETER MUSCLE; MIXED INFECTION; MUSCLE METASTASIS; STOMATITIS; THROMBOCYTOPENIA; TUMOR BIOPSY; ZYGOMA;

EID: 54749127328     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400424     Document Type: Article

References (12)

1. Schwartz JD, Sung M, Schwartz M, Lehrer D, Mandeli J, Liebes L, Goldenberg A, Volm M: Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-α2a upon progression. Oncologist, 10: 718-727, 2005.
2. Coban S, Yüksel O, Köklü S, Ceyhan K, Baykara M, Dökmeci A: Atypical presentation of hepatocellular carcinoma: a mass on the left thoracic wall. BMC Cancer, 4: 89, 2004.
3. Puoti M, Bruno R, Soriano V, Donato F, Gaeta GB, Quinzan GP, Precone D, Gelatti U, Asensi V, Vaccher E; HIV HCC Cooperative Italian-Spanish Group: Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS, 18: 2285-2293, 2004.
4. Rosenthal E, Poirée M, Pradier C, Perrone C, Salmon-Ceron D, Geffray L, Myers RP, Morlat P, Pialoux G, Pol S, Cacoub P; GERMIVIC Joint Study Group: Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS, 17: 1803-1809, 2003.
5. WHO handbook for reporting results of cancer treatment. WHO offset publication No. 48. World Health Organization, Geneva, 1979.
6. Gorusu M, Aziz K: Unusual presentation of hepatocellular carcinoma: a case report. Conn Med, 66: 457-460, 2002.
7. Katyal S, Oliver JH, Peterson MS, Ferris JV, Carr BS, Baron RL: Extrahepatic metastases of hepatocellular carcinoma. Radiology, 216: 698-703, 2000.
8. Pawarode A, Voravud N, Sriurapong V, Kullavanijaya P, Patt YZ: Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol, 21: 386-391, 1998.
9. Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi R, Sakamoto K, Ikari T: Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases autopsied in ten years. Cancer, 51: 863-877, 1983.
10. Bruno R, Puoti M, Sacchi P, Filice C, Carosi G, Filice G: Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. J Hepatol, 44: S146-S150, 2006.
11. Altavilla G, Caputo A, Lanfredi M, Piola C, Barbanti-Brodano G, Corallini A: Enhancement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol, 157: 1081-1089, 2000.
12. Aguayo A, Patt Y: Nonsurgical treatment of hepatocellular carcinoma. Semin Oncol, 28: 503-513, 2001.